Ontology highlight
ABSTRACT: Background
No in-depth systematic evidence is available for assessing retinoblastoma malignancy and eligibility for subsequent treatment.Methods
The Cochrane Library, EMBASE, PubMed, Web of Science, and China Biology Medicine databases were searched, and 16 studies comprising 718 retinoblastoma patients were included. Pooled odds ratios (ORs) and summary correlation coefficients (r) with 95% confidence intervals (CIs) in random-effects, fixed-effects or quality-effects models were calculated using Review Manager 5.3 and MetaXL. GO functional annotation and KEGG pathway analysis were performed using the GO and STRING databases.Results
We observed significant associations between high levels of MMP-1 (OR, 4.21; 95% CI 1.86-9.54), MMP-2 (OR, 11.18; 95% CI 4.26-29.30),
SUBMITTER: Zhu J
PROVIDER: S-EPMC6636009 | biostudies-literature | 2019 Jul
REPOSITORIES: biostudies-literature